Home › Tumori cerebrali › New York › New York City
Studi clinici su Tumori cerebrali a New York City, NY
25 studi su Tumori cerebrali cercano partecipanti presso sedi a New York City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
In reclutamentoFase 2
- New York University Langone's Perlmutter Cancer Institute, New York
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
In reclutamentoFase 2
- Columbia University Irving Medical Center, New York
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
In reclutamentoFase 1/2
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
In reclutamentoFase 2
- Local Institution - 0170, New York
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1/1b Study of IAM1363 in HER2 Cancers
In reclutamentoFase 1
- Icahn School of Medicine at Mount Sinai, New York
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
In reclutamentoFase 2
- Memorial Sloan-Kettering Cancer Center, New York
Chronic CED of TPT for Recurrent Malignant Glioma
In reclutamentoFase 1
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
In reclutamentoFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
European Prospective Investigation Into Childhood Cancer
In reclutamentoStudio osservazionale
- Columbia University Irving Medical Center, New York
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
In reclutamentoFase 1/2
- Lenox Hill Brain Tumor Center, New York
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
In reclutamentoFase 3
- Lenox Hill Brain Tumor Center, New York
Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
In reclutamento
- Lenox Hill Brain Tumor Center, New York
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
In reclutamento
- Lenox Hill Brain Tumor Center, New York
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
In reclutamentoFase 1/2
- Lenox Hill Brain Tumor Center, New York
A Study of Sotorasib in People With Brain Tumors
In reclutamentoFase 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Brodalumab in the Treatment of Immune-Related Adverse Events
In reclutamentoFase 1
- Columbia University Irving Medical Center, New York
rTMS for Postoperative Brain Tumor Patients
In reclutamento
- Columbia University Irving Medical Center, New York
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
In reclutamentoFase 1/2
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
In reclutamentoFase 2
- Lenox Hill Brain Tumor Center, New York
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
In reclutamentoFase 1/2
- Weill Cornell Medicine, New York
- Brooklyn Methodist Hospital - NewYork Presbyterian, New York
- New York Presbyterian Hospital - Queens, New York
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
In reclutamentoFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
FUS Etoposide for DMG
In reclutamentoFase 1
- Columbia University Irving Medical Center, New York
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
In reclutamentoFase 4
- New York-Presbyterian/Weill Cornell Medical Center, New York
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
In reclutamento
- Memorial Sloan Kettering Cancer Center, New York
Studi su Tumori cerebrali in altre città
- Houston, TX35 studi
- Boston, MA28 studi
- Washington, DC20 studi
- Los Angeles, CA16 studi
- Miami, FL15 studi
- Durham, NC14 studi
- St. Louis, MO12 studi
- Rochester, MN11 studi
- Chicago, IL11 studi
- Cleveland, OH11 studi
- Baltimore, MD11 studi
- Seattle, WA11 studi
Altri studi a New York City
- Cancro al seno136 studi
- Cancro del polmone non a piccole cellule121 studi
- Cancro (tutti i tipi)109 studi
- Cancro alla prostata103 studi
- Cancro metastatico93 studi
- Cancro colorettale78 studi
- Cancro ovarico69 studi
- Cancro ai polmoni60 studi
- Mieloma multiplo60 studi
- Cancro pancreatico60 studi
- Cancro dell'endometrio52 studi
- Leucemia mieloide acuta51 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.